FemTech, a rapidly expanding sector of technologies focused on women's health, is an emerging global health megatrend. These technologies impact how menstrual health, fertility, contraception, pregnancy, menopause, and sexual wellbeing are understood and managed. From a health systems perspective, FemTech is best conceptualised as a digitally enabled women's health sector that predominantly operationalises personalised, data-driven care. Most commercial FemTech platforms rely on user-generated data, behavioural analytics, and symptom tracking to individualise recommendations. Using insights from research on young women's sexuality, gendered power relations, and reproductive experiences in low- and middle-income countries, I argue that FemTech can realise its full potential when embedded within equity-driven care models. The paper contrasts the creation and utilisation of FemTech in high-income countries and low- and middle-income countries, and concludes by providing strategies for equity-oriented FemTech.
No takes yet. Share an insight, caveat, or question.
Nompumelelo Gloria Mfeka-Nkabinde (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: